Sabra Health Care REIT, Inc.
General ticker "SBRA" information:
- Sector: Real Estate
- Industry: REIT - Healthcare Facilities
- Capitalization: $4.2B (TTM average)
Sabra Health Care REIT, Inc. follows the US Stock Market performance with the rate: 38.3%.
Estimated limits based on current volatility of 0.9%: low 18.39$, high 18.71$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-11-17, amount 0.30$ (Y6.41%)
- Total employees count: 50 as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Labor/talent shortage/retention, Pandemic risks, Regulatory and compliance, Market competition, Occupancy rates
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [14.52$, 18.68$]
- 2025-12-31 to 2026-12-31 estimated range: [14.34$, 18.65$]
Financial Metrics affecting the SBRA estimates:
- Positive: with PPE of 11.8 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 36.55 > 18.34
- Positive: 6.66 < Operating cash flow per share per price, % of 7.82
- Negative: Industry earnings per price (median), % of 3.30 <= 4.47
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: 42.77 < Shareholder equity ratio, % of 51.69 <= 64.37
- Positive: 1.84 < Return on assets ratio (scaled to [-100,100]) of 2.33
- Negative: 0.73 < Interest expense per share per price, % of 2.90
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term SBRA quotes
Long-term SBRA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $624.81MM | $647.51MM | $703.24MM |
| Operating Expenses | $389.97MM | $425.80MM | $446.21MM |
| Operating Income | $234.84MM | $221.71MM | $257.03MM |
| Non-Operating Income | $-311.20MM | $-205.95MM | $-129.31MM |
| Interest Expense | $105.47MM | $112.96MM | $115.27MM |
| Income(Loss) | $-76.36MM | $15.76MM | $127.72MM |
| Taxes | $1.24MM | $2.00MM | $1.00MM |
| Profit(Loss)* | $-77.61MM | $13.76MM | $126.71MM |
| Stockholders Equity | $3,056.39MM | $2,802.53MM | $2,741.29MM |
| Assets | $5,747.67MM | $5,386.15MM | $5,303.68MM |
| Operating Cash Flow | $315.73MM | $300.57MM | $310.54MM |
| Investing Cash Flow | $-216.25MM | $103.13MM | $-109.00MM |
| Financing Cash Flow | $-161.71MM | $-410.30MM | $-181.56MM |
| Earnings Per Share** | $-0.34 | $0.06 | $0.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.